Clinical Trial: Impact of Long-term Dutasteride Use on Perioperative Outcomes of HoLEP

U.S., Feb. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07417449) titled 'Impact of Long-term Dutasteride Use on Perioperative Outcomes of HoLEP' on Feb. 11.

Brief Summary: This study aims to investigate the effects of long-term dutasteride use (a 5-alpha reductase inhibitor) on surgical outcomes in patients undergoing Holmium Laser Enucleation of the Prostate (HoLEP) for benign prostatic hyperplasia (BPH).

While some studies suggest that short-term use of these medications can reduce bleeding during surgery, there is limited data on the impact of chronic, long-term use (at least 6 months) specifically during the HoLEP procedure.

The researchers will retrospectively analyze patient records to compare tw...